Cg Oncology Inc. [CGON] stock prices are up 5.53% to $39.11 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CGON shares have gain 12.29% over the last week, with a monthly amount glided 10.26%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Cg Oncology Inc. [NASDAQ: CGON] stock has seen the most recent analyst activity on August 28, 2024, when ROTH MKM initiated its Buy rating and assigned the stock a price target of $65. Previously, BofA Securities started tracking the stock with Buy rating on June 28, 2024, and set its price target to $65. On February 20, 2024, Morgan Stanley initiated with a Overweight rating and assigned a price target of $55 on the stock. Goldman started tracking the stock assigning a Neutral rating and suggested a price target of $42 on February 20, 2024. Cantor Fitzgerald initiated its recommendation with a Overweight and recommended $75 as its price target on February 20, 2024. H.C. Wainwright started tracking with a Buy rating for this stock on February 14, 2024, and assigned it a price target of $75.
The stock price of Cg Oncology Inc. [CGON] has been fluctuating between $25.77 and $50.23 over the past year. Currently, Wall Street analysts expect the stock to reach $63.5 within the next 12 months. Cg Oncology Inc. [NASDAQ: CGON] shares were valued at $39.11 at the most recent close of the market. An investor can expect a potential return of 62.36% based on the average CGON price forecast.
Analyzing the CGON fundamentals
Gross Profit Margin for this corporation currently stands at 0.98% with Operating Profit Margin at -125.72%, Pretax Profit Margin comes in at -98.7%, and Net Profit Margin reading is -98.7%. To continue investigating profitability, this company’s Return on Assets is posted at -0.11, Equity is -0.21 and Total Capital is -0.15. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 37.68 points at the first support level, and at 36.26 for the second support level. However, for the 1st resistance point, the stock is sitting at 40.08, and for the 2nd resistance point, it is at 41.06.
Ratios To Look Out For
It’s worth pointing out that Cg Oncology Inc. [NASDAQ:CGON]’s Current Ratio is 47.57. As well, the Quick Ratio is 47.57, while the Cash Ratio is 2.12.
Transactions by insiders
Recent insider trading involved Song Hong Fang, Director, that happened on Aug 29 ’24 when 0.65 million shares were sold. Director, Unique Diamond Investments Ltd completed a deal on Aug 29 ’24 to buy 0.42 million shares. Meanwhile, Director Charming Jade Ltd bought 0.23 million shares on Aug 29 ’24.
